{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:27:38Z","timestamp":1787761658877,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The traditional healthcare systems are being avidly looked into in the quest for effective remedies to tackle the menace of COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This was a prospective randomized, controlled open-label, blinded end point (PROBE) study to evaluate the efficacy and safety of a fixed ayurvedic regimen (FAR) as an add-on to conventional treatment\/standard of care (SOC) in the management of mild-to-moderate COVID-19 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>\n                      A total of 68 patients were recruited who consumed either FAR + SOC (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 35) or SOC only (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 33) for 28 days. Primary outcomes assessed were mean time required for clinical recovery and proportion of patients showing clinical recovery between the groups. Secondary outcomes assessed included mean time required for testing SARS-CoV-2 negative, change in clinical status on World Health Organization (WHO) ordinal scale, number of days of hospitalization, change in disease progression and requirement of oxygen\/intensive care unit admission\/ventilator support\/rescue medication, health status on WHO quality of life (QOL) BREF and safety on the basis of occurrence of adverse event\/serious adverse event (AE\/SAE) and changes in laboratory parameters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Patients consuming FAR as an add-on SOC showed faster clinical recovery from the day of onset of symptoms by 51.34% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) as compared to SOC group. A higher proportion of patients taking FAR recovered within the first 2 weeks compared to those taking only SOC. It was observed that 5 times more patients recovered within 7 days in FAR group when compared to SOC (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) group. An earlier clinical recovery was observed in clinical symptoms such as sore throat, cough, loss of taste and myalgia (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Improvement in postclinical symptoms such as appetite, digestion, stress and anxiety was also obs served to be better with the use of FAR. Requirement of rescue medications such as antipyretics, analgesics and antibiotics was also found to be reduced in the FAR group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). FAR showed a significant improvement in all the assessed domains of QOL. None of the AEs\/SAE reported in the study were assessed to be related to the study drugs. Further, FAR did not produce any significant change in the laboratory safety parameters and was assessed to be safe.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>FAR could be an effective and safe add-on ayurvedic regimen to standard of care in the management of mild and moderate COVID-19 patients. CTRI number: CTRI\/2020\/09\/027914.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_242_21","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T05:13:37Z","timestamp":1675746817000},"page":"256-267","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Prospective, Randomized, Open-Label, Blinded End Point, Two-Arm, Comparative Clinical Study to Evaluate the Efficacy and Safety of a Fixed Ayurvedic Regimen (FAR) as Add-on to Conventional Treatment in the Management of Mild and Moderate COVID-19 Patients"],"prefix":"10.4103","volume":"13","author":[{"given":"Arun","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasibhushan","family":"Vedula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Tamoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Mundhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D N","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiren Baburao","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiva K","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-16-20240829","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijsu.2020.04.001","article-title":"Evidence based management guideline for the COVID-19 pandemic-Review article","volume":"77","author":"Nicola","year":"2020","journal-title":"Int J Surg"},{"key":"R3-16-20240829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jaim.2020.06.012","article-title":"AYUSH for COVID-19 management","volume":"11","author":"Tillu","year":"2020","journal-title":"J Ayurveda Integr Med"},{"key":"R6-16-20240829","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","article-title":"Viral dynamics in mild and severe cases of COVID-19","volume":"20","author":"Liu","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R9-16-20240829","first-page":"140","article-title":"World Health Organization Quality-of-Life Scale (WHOQOL-BREF): Analyses of their item response theory properties based on the graded responses model","volume":"5","author":"Vahedi","year":"2010","journal-title":"Iran J Psychiatry"},{"key":"R10-16-20240829","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1472-6882-12-248","article-title":"Prakriti (ayurvedic concept of constitution) and variations in platelet aggregation","volume":"12","author":"Bhalerao","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"R12-16-20240829","first-page":"26","article-title":"Assessment of Agni (digestive function) and Koshtha (bowel movement with special reference to Abhyantara snehana (internal oleation)","volume":"28","author":"Patil","year":"2008","journal-title":"Anc Sci Life"},{"key":"R13-16-20240829","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/2156587216656117","article-title":"Development, validation and verification of a self-assessment tool to estimate agnibala (digestive strength)","volume":"22","author":"Singh","year":"2017","journal-title":"J Evid Based Complementary Altern Med"},{"key":"R16-16-20240829","doi-asserted-by":"crossref","first-page":"153494","DOI":"10.1016\/j.phymed.2021.153494","article-title":"Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients","volume":"84","author":"Devpura","year":"2021","journal-title":"Phytomedicine"},{"key":"R25-16-20240829","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5005\/jras-10064-0110","article-title":"Pathogenesis of COVID 19: A review on integrative understanding through Ayurveda","volume":"4","author":"Gurao","year":"2020","journal-title":"J Res Ayurvedic Sci"},{"key":"R27-16-20240829","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12906-018-2238-1","article-title":"Evaluation of antiviral activity of Ocimum sanctum and Acacia Arabica leaves extracts against H9N2 virus using embryonated chicken egg model","volume":"18","author":"Ghoke","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"R29-16-20240829","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0974-8520.141958","article-title":"Anti-inflammatory activity of Guduchi Ghana (aqueous extract of Tables Tinospora cordifolia Miers.)","volume":"35","author":"Patgiri","year":"2014","journal-title":"Ayu"},{"key":"R30-16-20240829","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/13880209109082904","article-title":"Anti-asthmatic and anti-inflammatory activity of Ocimum sanctum","volume":"29","author":"Singh","year":"1991","journal-title":"Int J Pharmacogn"},{"key":"R31-16-20240829","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.intimp.2008.12.002","article-title":"In vitro and in vivo anti-inflammatory effects of andrographolide","volume":"9","author":"Abu-Ghefreh","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"R32-16-20240829","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jep.2012.03.027","article-title":"Immunomodulatory active compounds from Tinospora cordifolia","volume":"141","author":"Sharma","year":"2012","journal-title":"J Ethnopharmacol"},{"key":"R34-16-20240829","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/aps.2009.205","article-title":"Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"R35-16-20240829","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3109\/13880200903008690","article-title":"The protective effect of Tinospora cordifolia on various mast cell mediated allergic reactions","volume":"47","author":"Zalawadia","year":"2009","journal-title":"Pharm Biol"},{"key":"R36-16-20240829","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3389\/fphar.2019.00677","article-title":"Lamiaceae: An insight on their anti-allergic potential and its mechanisms of action","volume":"10","author":"Sim","year":"2019","journal-title":"Front Pharmacol"},{"key":"R37-16-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/phbi.36.1.72.4620","article-title":"Antiallergic activity of andrographolides isolated from Andrographis paniculata (Burm.F) Wall","volume":"36","author":"Gupta","year":"1998","journal-title":"Pharm Biol"},{"key":"R38-16-20240829","doi-asserted-by":"crossref","first-page":"957","DOI":"10.17219\/acem\/27909","article-title":"The analgesic, anti-inflammatory and anti-pyretic activities of Tinospora cordifolia","volume":"24","author":"Hussain","year":"2015","journal-title":"Adv Clin Exp Med"},{"key":"R39-16-20240829","first-page":"55","article-title":"Evaluation of anti-pyretic activity of Ocimum sanctum Linn using Brewer's yeast induced pyrexia in albino rats","volume":"1","author":"Balakrishna","year":"2017","journal-title":"J Innov Pharm Sci"},{"key":"R40-16-20240829","first-page":"399","article-title":"Antipyretic activities of some species of Andrographis wall","volume":"12","author":"Balu","year":"1993","journal-title":"Anc Sci Life"},{"key":"R41-16-20240829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0378-8741(98)00164-0","article-title":"Antioxidant activity of Tinospora cordifolia roots in experimental diabetes","volume":"65","author":"Prince","year":"1999","journal-title":"J Ethnopharmacol"},{"key":"R42-16-20240829","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1007\/s13197-020-04417-2","article-title":"Phytochemical and antioxidant profiling of Ocimum sanctum","volume":"57","author":"Chaudhary","year":"2020","journal-title":"J Food Sci Technol"},{"key":"R43-16-20240829","first-page":"49","article-title":"Evaluation of beneficial effects of antioxidant properties of aqueous leaf extract of Andrographis paniculata in STZ-induced diabetes","volume":"22","author":"Dandu","year":"2009","journal-title":"Pak J Pharm Sci"},{"key":"R44-16-20240829","first-page":"158","article-title":"Evaluation of immunostimulatory activity of Chyawanprash using in vitro assays","volume":"53","author":"Madaan","year":"2015","journal-title":"Indian J Exp Biol"},{"key":"R45-16-20240829","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/asl.ASL_8_17","article-title":"Evaluation of cyavanaprasa on health and immunity related parameters in healthy children: A two arm, randomized, open labelled, prospective, multicenter, clinical study","volume":"36","author":"Gupta","year":"2017","journal-title":"Anc Sci Life"},{"key":"R46-16-20240829","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/biom9050161","article-title":"Chyawanprash: A traditional Indian bioactive health supplement","volume":"9","author":"Sharma","year":"2019","journal-title":"Biomolecules"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_242_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:04:22Z","timestamp":1787760262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_242_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_242_21","relation":{},"ISSN":["0976-4879"],"issn-type":[{"value":"0976-4879","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}